Copyright
©The Author(s) 2024.
World J Psychiatry. Sep 19, 2024; 14(9): 1308-1318
Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1308
Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1308
Table 1 Demographic and clinical characteristics, n (%)
Index | Control group | Generalized anxiety disorder group | t/χ2 | P value |
Age (yr) | 53.79 ± 16.23 | 58.30 ± 13.70 | 1.863 | 0.065 |
Sex (male/female) | 25/45 | 39/50 | 1.812 | 0.178 |
Body mass index (kg/m2) | 24.55 ± 2.06 | 24.46 ± 3.24 | 0.291 | 0.760 |
Smoking history | 19 (27.14) | 18 (20.22) | 1.050 | 0.305 |
Drinking history | 9 (12.85) | 8 (8.99) | 0.001 | 0.529 |
Diabetes | 10 (14.29) | 13 (14.60) | 0.030 | 0.954 |
Hypertension | 33 (47.14) | 46 (51.69) | 0.323 | 0.570 |
Coronary heart disease | 8 (11.42) | 18 (20.22) | 2.216 | 0.137 |
Hyperlipidemia | 7 (10.00) | 10 (11.23) | 0.063 | 0.802 |
Cerebral infarction | 10 (14.28) | 15 (16.85) | 0.195 | 0.659 |
- Citation: Wang WY, Liu N, Qi XX, Han B, Sun JN, Chen ZL, Wang MW, Wang YY. Predictive effect of lipopolysaccharide-stimulated inflammatory cytokines on symptoms of generalized anxiety disorder. World J Psychiatry 2024; 14(9): 1308-1318
- URL: https://www.wjgnet.com/2220-3206/full/v14/i9/1308.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i9.1308